{"id":"W2161692381","doi":"10.1093/annonc/mdr021","title":"Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Response Biomedical (Canada)","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Lapatinib; Internal medicine; Cancer; Metastatic breast cancer; Oncology; Crizotinib; Angiogenesis; Phases of clinical research; Epidermal growth factor receptor; Gastroenterology; Breast cancer; Chemotherapy; Trastuzumab; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005292191,0.000263439,0.001325807,0.0004634936,0.00004644335,0.000002202774,0.0002039919,0.0000922938,0.0009604566],"category_scores_gemma":[0.0001865912,0.000175527,0.0001213974,0.0006659072,0.0001614527,0.0001112634,0.00008949045,0.0002004146,0.000004731567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009267731,"about_ca_system_score_gemma":0.0004482522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001655877,"about_ca_topic_score_gemma":0.003860091,"domain_scores_codex":[0.9977403,0.000193733,0.0009233018,0.0003751251,0.0003563156,0.0004112534],"domain_scores_gemma":[0.9981724,0.0002445011,0.0007742556,0.000360975,0.0003253473,0.0001225131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3861181,0.04487775,0.1780503,0.00007708922,0.0007779539,0.0001382835,0.00504693,0.0000109468,0.0000191277,0.00002527884,0.0004801468,0.3843781],"study_design_scores_gemma":[0.3366014,0.4530604,0.2012045,0.00006545978,0.0003161858,0.000003154829,0.001266341,0.000005397472,0.00009926562,0.00004214525,0.007180517,0.0001552537],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941849,0.000146283,0.00002343098,0.0006879005,0.0003019285,0.00334647,0.00003611385,0.00002038901,0.001252571],"genre_scores_gemma":[0.9968535,0.0006984677,0.000777014,0.0008678408,0.0000708659,0.0004221402,0.0000311019,0.00002954907,0.0002495321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4081826,"threshold_uncertainty_score":0.9999528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1451100644784034,"score_gpt":0.4255288335353503,"score_spread":0.2804187690569468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}